Patent details

Basic Information

Publication number:

EP1808490

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP061240743

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Genetically engineered bleb vaccine

French Title of Invention:

Vaccin à bleb mis au point par génie génétique

German Title of Invention:

Genetisch manipulierter Bleb Impfstoff

SPC Number:

Dates

Filing date:

31/07/2000

Grant date:

14/11/2012

EP Publication Date:

14/11/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/07/2007

EP B1 Publication Date:

14/11/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

31/07/2020

Renunciation date:

Revocation date:

31/07/2013

Annulment date:

Owner

From:

31/07/2000

 

 

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

Inventor

1

Name:

Thonnard Joelle

Address:

Belgium (BE)

2

Name:

Berthet Francois-Xavier Jacques

Address:

Belgium (BE)

3

Name:

Thiry Georges

Address:

Belgium (BE)

4

Name:

Lobet Yves

Address:

Belgium (BE)

5

Name:

Denoel Philippe

Address:

Belgium (BE)

6

Name:

Poolman Jan

Address:

Belgium (BE)

7

Name:

Feron Christiane

Address:

Belgium (BE)

8

Name:

Dequesne Guy

Address:

Belgium (BE)

9

Name:

Voet Pierre

Address:

Belgium (BE)

10

Name:

Dalemans Wilfred L. J.

Address:

Belgium (BE)

Priority

Priority Number:

9918319

Priority Date:

03/08/1999

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07K 14/195;

Filing date	Document type	Number of pages